Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Fig. 3

PD-L1 expression and tumour mutational burden (TMB) in cervical cancer. A Distribution of PD-L1 expression in different histological subtypes of cervical cancer. Comparison of PD-L1 expression (B) and TMB (C) between cervical squamous cell carcinoma (SCC) and cervical adenocarcinoma (AC). C1: CPS < 1; C2: 1 ≤ CPS < 10; and C3: CPS ≥ 10. (D) Associations between TMB and mutations in the KMT2C, LRP1B, PIK3CA, KMT2D, FBXW7, FAT1, LRP2, ARID1A, EP300, KMT2A, PRKDC, and SPEN genes. *p < 0.05; **p < 0.01; ***p < 0.001. WT, wild-type; MT, mutant type

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us